ONTTF News and Press, Oxford Nanopore From 05/26/22

Oxford Nanopore integrates "Remora": a tool to enable real-time, high-accuracy epigenetic insights with nanopore sequencing software MinKNOW Oxford Nanopore has today released Remora, a high-performance tool for methylation analysis, into its operating software, MinKNOW, broadening ...

Oxford Nanopore delivers technology update at annual London Calling conference: bringing together years of innovation to showcase one sensing platform for all biological analyses OXFORD, UK / ACCESSWIRE / May 20, 2022 / At the annual London Calling conference, CTO Clive Brown and collea...

Oxford Nanopore's London Calling conference opens; amongst a breadth of ground-breaking research, increasing attention on human and cancer genomics Conference presentations set to highlight the utility of comprehensive genomic analysis using nanopore sequencing for novel discoveries in ...

Oxford Nanopore sequencing selected to generate comprehensive insights by characterising a more complete genome using samples from the 1000 Genomes Project Oxford Nanopore technology will enable the 1000 Genomes Project, spearheaded by researchers at the University of Washington and Sea...

PacBio shares have been hit hard as investors have abandoned riskier high-multiple life sciences stocks, and weaker guidance for FY'22 certainly didn't help. Illumina's announcement that it will enter long-read sequencing with its Infinity workflow offering is a threat, but I don't se...

Genomics England expands use of Oxford Nanopore sequencing in cancer Oxford Nanopore technology will be used by Genomics England to investigate and validate at increasing scale the benefits of sequencing for improving patient care and advancing research to develop new treatments. Genomi...

Oxford Nanopore technology update: CTO Clive G Brown unveils latest sequencing chemistry with highest performance to date, Short Fragment Mode and latest methylation performance evaluations Clive G Brown, CTO, Oxford Nanopore Technologies, reviews some of the latest technology updates d...

OXFORD, UK / ACCESSWIRE / March 24, 2022 / Oxford Nanopore announces positive evaluation of new method for rapid drug-resistant tuberculosis (DR-TB) profiling On World Tuberculosis Day, Oxford Nanopore, in collaboration with Quadram Institute Bioscience (QIB), announces that it has de...

Oxford Nanopore releases Short Fragment Mode: a new tool for real-time sequencing of short fragments of DNA Today, Short Fragment Mode will be integrated into the operating software that drives nanopore devices, allowing sequencing of fragments as short as 20 bases on nanopore platforms...

Oxford Nanopore Technologies Limited (ONTTF) Q4 2021 Results Conference Call March 22, 2022 05:30 AM ET Company Participants Gordon Sanghera - Chief Executive Officer Tim Cowper - Chief Financial Officer Conference Call Participants Steean Hamill - Numis Charles Weston - RBC James Gordon - JP...